Profile data is unavailable for this security.
About the company
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
- Revenue in USD (TTM)11.02bn
- Net income in USD-355.00m
- Incorporated1931
- Employees38.00k
- LocationBaxter International IncOne Baxter ParkwayDEERFIELD 60015United StatesUSA
- Phone+1 (224) 948-2000
- Fax+1 (302) 655-5049
- Websitehttps://www.baxter.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | 3.44bn | -23.70m | 6.37bn | 11.40k | -- | 2.61 | 33.04 | 1.85 | -0.1562 | -0.1562 | 22.65 | 16.06 | 0.5481 | 1.44 | 5.23 | 301,763.80 | -0.3554 | 6.80 | -0.4523 | 9.20 | 48.00 | 50.00 | -0.6485 | 9.66 | 0.8877 | 9.34 | 0.4462 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Glaukos Corp | 469.82m | -87.61m | 6.46bn | 995.00 | -- | 8.39 | -- | 13.76 | -1.55 | -1.55 | 8.28 | 13.41 | 0.4879 | 1.76 | 6.06 | 472,180.90 | -9.10 | -11.24 | -9.92 | -12.04 | 76.87 | 73.54 | -18.65 | -36.68 | 4.47 | -- | 0.0817 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Masimo Corp | 1.72bn | -203.80m | 7.47bn | 3.60k | -- | 9.12 | -- | 4.36 | -3.83 | -10.61 | 31.70 | 15.25 | 0.6993 | 1.70 | 5.09 | 476,416.70 | -8.31 | 3.29 | -10.46 | 3.99 | 54.96 | 53.94 | -11.88 | 4.56 | 1.92 | 5.88 | 0.4084 | 0.00 | 2.26 | 17.43 | -474.11 | -- | -6.75 | -- |
| Avantor Inc | 6.58bn | -82.20m | 7.68bn | 13.50k | -- | 1.38 | 23.58 | 1.17 | -0.1203 | -0.1203 | 9.64 | 8.17 | 0.5364 | 5.58 | 6.07 | 487,051.80 | -0.6706 | 3.94 | -0.7693 | 4.48 | 33.13 | 33.76 | -1.25 | 6.87 | 0.9639 | 3.95 | 0.4092 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
| Repligen Corp | 707.89m | 1.74m | 8.00bn | 1.78k | 5,521.55 | 3.84 | 96.38 | 11.31 | 0.0258 | 0.0258 | 12.55 | 37.01 | 0.246 | 2.00 | 5.09 | 398,138.30 | 0.0604 | 3.28 | 0.063 | 3.70 | 51.59 | 54.24 | 0.2455 | 12.37 | 7.14 | -- | 0.2052 | 0.00 | 0.3285 | 18.61 | -171.68 | -- | 5.25 | -- |
| Bio Rad Laboratories Inc | 2.56bn | -675.90m | 8.10bn | 7.70k | -- | 1.21 | -- | 3.17 | -24.30 | -24.30 | 92.91 | 249.77 | 0.252 | 1.53 | 5.52 | 332,139.60 | -6.66 | 3.00 | -7.01 | 3.15 | 52.42 | 55.37 | -26.43 | 14.51 | 3.94 | 0.2476 | 0.1515 | 0.00 | -3.92 | 2.11 | -189.37 | -- | 13.91 | -- |
| Henry Schein Inc | 12.94bn | 391.00m | 9.39bn | 25.00k | 25.19 | 2.81 | 13.29 | 0.7254 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Baxter International Inc | 11.02bn | -355.00m | 11.17bn | 38.00k | -- | 1.54 | 17.65 | 1.01 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 11.52bn | 11.00k | 49.05 | 1.59 | 17.85 | 4.03 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.75bn | 5.30k | 28.38 | 2.69 | 16.79 | 4.24 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Guardant Health Inc | 902.57m | -398.79m | 13.12bn | 2.00k | -- | -- | -- | 14.54 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.38bn | 4.50k | 82.29 | 9.83 | 73.74 | 10.03 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.46bn | 20.95k | 33.15 | 3.32 | 32.83 | 3.34 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Solventum Corp | 8.40bn | 1.52bn | 13.55bn | 22.00k | 8.99 | 2.72 | 6.63 | 1.61 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to Baxter International Inc's reporting currency: US Dollar USD
60.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Pzena Investment Management LLCas of 31 Dec 2025 | 70.87m | 13.79% |
| Dodge & Coxas of 30 Sep 2025 | 57.40m | 11.17% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 57.39m | 11.16% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 31.32m | 6.09% |
| BlackRock Advisors LLCas of 30 Sep 2025 | 23.21m | 4.52% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 22.00m | 4.28% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2025 | 12.69m | 2.47% |
| Geode Capital Management LLCas of 30 Sep 2025 | 12.54m | 2.44% |
| Greenhaven Associates, Inc.as of 31 Dec 2025 | 10.69m | 2.08% |
| UBS Securities LLCas of 31 Dec 2025 | 10.57m | 2.06% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
